Eagle Asset Management Inc. lessened its stake in shares of Cooper Companies Inc (NYSE:COO) by 4.7% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 17,014 shares of the medical device company’s stock after selling 844 shares during the quarter. Eagle Asset Management Inc.’s holdings in Cooper Companies were worth $3,892,000 at the end of the most recent reporting period.
Other institutional investors also recently bought and sold shares of the company. BB&T Investment Services Inc. lifted its position in shares of Cooper Companies by 71.0% during the 4th quarter. BB&T Investment Services Inc. now owns 542 shares of the medical device company’s stock worth $119,000 after buying an additional 225 shares during the period. Signaturefd LLC bought a new position in shares of Cooper Companies during the 1st quarter worth approximately $144,000. Virtue Capital Management LLC bought a new position in shares of Cooper Companies during the 4th quarter worth approximately $195,000. Conning Inc. bought a new position in shares of Cooper Companies during the 1st quarter worth approximately $215,000. Finally, Everence Capital Management Inc. bought a new position in shares of Cooper Companies during the 4th quarter worth approximately $253,000. Institutional investors and hedge funds own 94.97% of the company’s stock.
COO has been the subject of several research analyst reports. TheStreet downgraded Cooper Companies from a “b” rating to a “c” rating in a research report on Thursday, March 8th. BMO Capital Markets reiterated an “outperform” rating and issued a $280.00 price objective (up previously from $277.00) on shares of Cooper Companies in a research report on Friday, March 9th. Oppenheimer set a $265.00 price objective on Cooper Companies and gave the company a “hold” rating in a research report on Friday, March 9th. Stephens reiterated a “hold” rating and issued a $270.00 price objective on shares of Cooper Companies in a research report on Friday, March 9th. Finally, Jefferies Group reiterated a “buy” rating and issued a $285.00 price objective on shares of Cooper Companies in a research report on Friday, March 9th. Eight analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus target price of $264.91.
In other news, Director Michael Kalkstein sold 1,715 shares of Cooper Companies stock in a transaction on Wednesday, April 11th. The stock was sold at an average price of $221.66, for a total value of $380,146.90. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Carol R. Kaufman sold 13,362 shares of Cooper Companies stock in a transaction on Monday, March 12th. The shares were sold at an average price of $243.88, for a total value of $3,258,724.56. Following the completion of the sale, the executive vice president now directly owns 59,305 shares of the company’s stock, valued at $14,463,303.40. The disclosure for this sale can be found here. Insiders sold a total of 51,846 shares of company stock valued at $12,549,839 over the last three months. Insiders own 1.60% of the company’s stock.
Cooper Companies opened at $227.75 on Friday, according to MarketBeat.com. The firm has a market capitalization of $11.25 billion, a PE ratio of 23.48, a PEG ratio of 1.81 and a beta of 0.62. Cooper Companies Inc has a 52 week low of $215.24 and a 52 week high of $260.26. The company has a quick ratio of 1.61, a current ratio of 2.83 and a debt-to-equity ratio of 0.75.
Cooper Companies (NYSE:COO) last released its earnings results on Thursday, March 8th. The medical device company reported $2.79 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.51 by $0.28. The company had revenue of $590.00 million during the quarter, compared to analysts’ expectations of $583.07 million. Cooper Companies had a return on equity of 16.90% and a net margin of 7.83%. The business’s revenue for the quarter was up 18.2% on a year-over-year basis. During the same period last year, the firm earned $1.93 EPS. equities research analysts expect that Cooper Companies Inc will post 11.82 EPS for the current year.
About Cooper Companies
The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.
Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cooper Companies Inc (NYSE:COO).
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.